Ami Asset Management Corp Karyopharm Therapeutics Inc. Transaction History

Ami Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$4.45 - $10.63 $2.29 Million - $5.46 Million	-514,101 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$8.11 - $11.11 $104,854 - $143,641	12,929 Added 2.58%	514,101 $5.31 Million
Q1 2021 Apr 16, 2021	BUY	$9.85 - $17.69 $1.42 Million - $2.54 Million	143,823 Added 40.25%	501,172 $5.27 Million
Q4 2020 Jan 20, 2021	SELL	$14.15 - $17.19 $3.62 Million - $4.39 Million	-255,613 Reduced 41.7%	357,349 $5.53 Million
Q3 2020 Oct 23, 2020	BUY	$14.14 - $19.71 $8.67 Million - $12.1 Million	612,962 New	612,962 $8.95 Million

56.5M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Ami Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Ami Asset Management Corp with notifications on news.